European Commission Approves Enhanced Wegovy Ob...

By João L. Carapinha

February 18, 2026

European Commission Backs Wegovy Obesity Treatment with 7.2 mg Dose The European Commission has approved a higher 7.2 mg maintenance dose of
Genotype ECG Prediction
South Africa Health Reform: Navigating Innovations and Challenges for 2026
CHMP January 2026 Approvals: Expanding Access to Innovative Therapies
Latin America Pharma Growth: Boehringer Ingelheim’s Strategic Investmen...
β-Blockers Myocardial Infarction: Reevaluating Their Role in Patients with Pr...
Bausch Health’s Strategic Growth in Latin American Pharmaceuticals Thro...
CHMP Meeting Highlights: December 2025 Advances in New Medicines Approvals
2025 China Drug Catalog Boosts Access with 114 New Drugs and Innovative Solut...
NICE Approves Seven Digital Cardiac Rehabilitation Technologies for Enhanced ...
GLP-1RAs Psychiatric Care: Transforming Metabolic Management for Psychotropic...
Accelerating Access to Latin America Innovative Therapies Through Collaborati...
Health Investment Returns: Harnessing Health as a Strategic Economic Asset